Martijn H, Vulto J C M
Department of Radiotherapy, Catharina Hospital, P.O. Box 1350, 5602 ZA Eindhoven, The Netherlands.
Eur J Cancer. 2007 Oct;43(15):2301-6. doi: 10.1016/j.ejca.2007.06.014. Epub 2007 Aug 21.
Purpose is to give an overview of treatment possibilities of rectal cancer over time, but also of the real management of rectal cancer especially in relation to age. From literature search representative randomised studies on patients with resectable rectal cancer, comparing only surgery, post- and preoperative radiotherapy with or without chemotherapy, are reviewed. We also reviewed the literature regarding radiotherapy for rectal cancer described in population-based studies. The overview of the trials showed that preoperative radiotherapy improves local control in relation to no or postoperative radiotherapy. Adding chemotherapy did not significantly improve survival. No relations were seen between age and complications. All population-based studies showed that increasing age is associated with less (neo)adjuvant treatment. To avoid local recurrence, the best possible treatment, being preoperative RT, should be given to all patients with resectable rectal cancer, irrespective of age.
目的是概述直肠癌治疗方法随时间的变化情况,同时也概述直肠癌的实际治疗管理,尤其是与年龄相关的情况。通过文献检索,对关于可切除直肠癌患者的代表性随机研究进行综述,这些研究仅比较了手术、术前和术后放疗(有无化疗)。我们还综述了基于人群研究中描述的直肠癌放疗相关文献。试验综述表明,与未放疗或术后放疗相比,术前放疗可改善局部控制。添加化疗并未显著提高生存率。未发现年龄与并发症之间存在关联。所有基于人群的研究均表明,年龄增长与较少的(新)辅助治疗相关。为避免局部复发,对于所有可切除直肠癌患者,无论年龄大小,均应给予最佳可能的治疗,即术前放疗。